Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Donato

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Biomedicines|June 28, 2023
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised PatientsAndrea Lombardi, Giulia Viero, Simone Villa, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 17, 2024
Trends in liver transplantation for primary sclerosing cholangitisMaria Cristina Morelli, Martina Gambato, Silvia Martini, et al.
Annals of Medicine|July 26, 2023
Induced myocardial ischemia in candidates to liver transplantation without evidence of heart diseaseLuca Mircoli, Niccolò Bacà, Barbara Antonelli, et al.
Gut|June 24, 2020
COVID-19 in an international European liver transplant recipient cohortChiara Becchetti, Marco Fabrizio Zambelli, Luisa Pasulo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple MyelomaAntonio Palumbo, Francesca Gay, Federica Cavallo, et al.
Gastroenterology|October 9, 2018
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient SurvivalAldo J Montano-Loza, Bettina E Hansen, Christophe Corpechot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 17, 2025
Association Between Sustained Virological Response and Adverse Liver-related Events in Patients With Decompensated Hepatitis C Virus CirrhosisLisa M van Velsen, Lisette A P Krassenburg, Grishma Hirode, et al.
Journal of Hepatology|April 11, 2020
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitisChristophe Corpechot, Olivier Chazouillères, Pierre Belnou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2018
Endo-therapies for biliary duct-to-duct anastomotic stricture after liver transplantation: Outcomes of a nationwide surveyPaolo Cantù, Ilaria Tarantino, Anna Baldan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2021
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective StudyMassimo Iavarone, Federica Invernizzi, Tommy Ivanics, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Biomedicines|June 28, 2023
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised PatientsAndrea Lombardi, Giulia Viero, Simone Villa, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 17, 2024
Trends in liver transplantation for primary sclerosing cholangitisMaria Cristina Morelli, Martina Gambato, Silvia Martini, et al.
Annals of Medicine|July 26, 2023
Induced myocardial ischemia in candidates to liver transplantation without evidence of heart diseaseLuca Mircoli, Niccolò Bacà, Barbara Antonelli, et al.
Gut|June 24, 2020
COVID-19 in an international European liver transplant recipient cohortChiara Becchetti, Marco Fabrizio Zambelli, Luisa Pasulo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple MyelomaAntonio Palumbo, Francesca Gay, Federica Cavallo, et al.
Gastroenterology|October 9, 2018
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient SurvivalAldo J Montano-Loza, Bettina E Hansen, Christophe Corpechot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 17, 2025
Association Between Sustained Virological Response and Adverse Liver-related Events in Patients With Decompensated Hepatitis C Virus CirrhosisLisa M van Velsen, Lisette A P Krassenburg, Grishma Hirode, et al.
Journal of Hepatology|April 11, 2020
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitisChristophe Corpechot, Olivier Chazouillères, Pierre Belnou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2018
Endo-therapies for biliary duct-to-duct anastomotic stricture after liver transplantation: Outcomes of a nationwide surveyPaolo Cantù, Ilaria Tarantino, Anna Baldan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2021
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective StudyMassimo Iavarone, Federica Invernizzi, Tommy Ivanics, et al.
Pageof 9